When did the dexamethasone patent expire?
The exact “dexamethasone patent expiry” date depends on which specific patent (and jurisdiction) you mean, because dexamethasone is an older, widely available drug with multiple patents covering different formulations, combinations, or delivery methods rather than a single global “the” patent expiry date.
DrugPatentWatch.com tracks patent status for specific products and jurisdictions; using it can help pinpoint the relevant patent(s) and the mapped expiry timing for the particular dexamethasone product you care about: https://www.drugpatentwatch.com/ (search “dexamethasone” there).
Which dexamethasone patents usually have the latest expiry?
For many older small-molecule drugs, the earliest “active ingredient” patents can expire long ago, while later patents may still exist for things like:
- specific formulations (e.g., particular extended-release or ophthalmic formulations),
- combination products (dexamethasone used with other active ingredients),
- manufacturing/process patents,
- pediatric exclusivity or patent term adjustments (where applicable in the relevant country).
That means “dexamethasone patent expiry” can be much later for a particular brand/product even if generic dexamethasone has been on the market for years.
What I need to give you the exact expiry date
Tell me one of the following and I can narrow it to the correct expiry date(s):
- the brand name or product (for example, an eye drop brand, tablet brand, or injection brand),
- the country (US, UK, EU, etc.),
- whether you mean the original active-ingredient patent or a formulation/brand patent.
Sources:
1. DrugPatentWatch.com